Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 82

Results For "IP"

11186 News Found

Bliss GVS Pharma files suit for IPR infringement
News | March 30, 2021

Bliss GVS Pharma files suit for IPR infringement

The company had filed a suit in the High Court of Justice, Ghana


Lupin Pharma Canada announces Partnership with Endoceutics
News | March 09, 2021

Lupin Pharma Canada announces Partnership with Endoceutics

Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.


IPA goes all out to develop a future roadmap for pharma sector
News | February 26, 2021

IPA goes all out to develop a future roadmap for pharma sector

Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.


Aurobindo Pharma to acquire 26% ownerships solar power companies
News | February 24, 2021

Aurobindo Pharma to acquire 26% ownerships solar power companies

The company will be holding 26% of the share capital in each of the solar power generating companies.


CIPLA Q3 FY21 PAT up to Rs. 748.15 Cr
News | February 01, 2021

CIPLA Q3 FY21 PAT up to Rs. 748.15 Cr

The company has reported total income of Rs.14759 crores during the 9 months period ended December 31, 2020.


India's clinical research ambitions need more than regulatory reforms: Experts
Clinical Trials | June 29, 2026

India's clinical research ambitions need more than regulatory reforms: Experts

At the latest Indian Pharma Post E-Conference, leading experts highlighted the need for accredited trial sites, skilled investigators, digital ecosystems, and greater public trust


Health Ministry proposes faster licensing timelines for medical device manufacturers
Policy | June 29, 2026

Health Ministry proposes faster licensing timelines for medical device manufacturers

The proposed changes seek to shorten the statutory timelines for granting manufacturing licences across various risk categories


India to launch revamped Anemia Mukt Bharat Abhiyaan with expanded 7x7x7 strategy
Policy | June 29, 2026

India to launch revamped Anemia Mukt Bharat Abhiyaan with expanded 7x7x7 strategy

The transition of the existing Anemia Mukt Bharat programme into Anemia Mukt Bharat Abhiyaan signals a shift towards a more comprehensive, technology-enabled and community-driven approach


Diabetes driving surge in early cataracts among Indians in 40s & 50s
Healthcare | June 29, 2026

Diabetes driving surge in early cataracts among Indians in 40s & 50s

India is home to more than 101 million adults living with diabetes and another 136 million with prediabetes


Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr
News | June 29, 2026

Strides Pharma divests majority stake in Pivot Path for Rs. 100 Cr

The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside